Sign in

What researchers published on Triple-negative breast cancer

19,690 papers, newest first.

Showing 40 of 19,690

  • MRI Radiomics-Based Nomogram Integrating Skeletal Muscle Assessment for Predicting Pathologic Complete Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer.Diagnostics (Basel, Switzerland)
  • β-galactosidase-activatable photosensitization for selective, light-amplified pyroptosis therapy of triple-negative breast Cancer cells.Bioorganic chemistry
  • In Vitro Models of Triple-Negative Breast Cancer of Sub-Saharan African Ancestry Suggest BLM-Centred DNA Damage Repair Dependency and Pevonedistat Sensitivity.International journal of molecular sciences
  • ReviewThe Role of Hypoxia-Inducible Factors (HIFs) in Triple-Negative Breast Cancer Radiation Resistance.International journal of molecular sciences
  • Leptin-Driven Distinct Transcriptional Reprogramming in Triple-Negative Breast Cancer: Implications for Racial Disparities.International journal of molecular sciences
  • Meta-analysisSurvival benefit of adding carboplatin to standard anthracycline-taxane chemotherapy in triple-negative breast cancer: an updated systematic review and meta-analysis.Breast cancer research and treatment
  • Promoter hypomethylation associated with elevated TRIM33 expression in triple-negative breast cancer patients.Frontiers in oncology
  • Early Change in the Pan-Immune-Inflammation Value During Neoadjuvant Chemotherapy Is Associated with Pathological Complete Response in HER2-Positive and Triple-Negative Breast Cancer: A Single-Centre Study with Temporal Validation.Journal of clinical medicine
  • ReviewRecent Advances in Mitochondria-Targeted Nanoparticle Photodynamic Therapy for Triple-Negative Breast Cancer.International journal of molecular sciences
  • RETRACTED: Kim et al. Autocrine Motility Factor and Its Peptide Derivative Inhibit Triple-Negative Breast Cancer by Regulating Wound Repair, Survival, and Drug Efflux. Int. J. Mol. Sci. 2024, 25, 11714.International journal of molecular sciences
  • Updated results from ASCENT-J02, a study of sacituzumab govitecan in Japanese participants with metastatic triple-negative breast cancer.International journal of clinical oncology
  • ReviewSQSTM1/p62 and Mitochondrial Stress in Triple-Negative Breast Cancer: A Critical Pathology Perspective.Cancers
  • Targeting AP1S1 modulates the unfolded protein response and cell cycle and sensitizes triple-negative breast cancer to erlotinib.Tissue & cell
  • Matrix-Associated Gene Expression and Annotated Tumor-Stroma Composition of Transcriptomically Defined Cold Regions in Triple-Negative Breast Cancer.Cancers
  • Oral 25-Hydroxycholesterol Suppresses 4T1 Tumour Growth in an Immune-Context-Associated Manner.International journal of molecular sciences
  • Neoadjuvant Versus Adjuvant Chemo-Immunotherapy in Early-Stage Triple-Negative Breast Cancer: A National Cancer Database Study.Cancers
  • ReviewCirculating Non-Coding RNAs as Liquid Biopsy Biomarkers for Early Detection of Triple-Negative Breast Cancer: From Diagnostic Performance to Clinical Translation.Diagnostics (Basel, Switzerland)
  • Cell-Cell Communication Network Analysis of Tertiary Lymphoid Structures in Triple-Negative Breast Cancer.Current cancer drug targets
  • CD39+CD71+ erythroid cells exhibit enhanced purine metabolism and T cell-suppressive function in triple-negative breast cancer and other immunoregulatory settings.Journal of immunology (Baltimore, Md. : 1950)
  • Dual-Targeted Nanoparticle Chimeras Induce Bioenergetic Crisis by Coupling Lipid Droplet Degradation with Nicotinamide Adenine Dinucleotide Reduction in Triple-Negative Breast Cancer.Acta biomaterialia
  • Targeting the SND1-MTDH/FANCD2 axis impairs DNA repair and sensitizes triple-negative breast cancer to PARP inhibitor.Pharmacological research
  • FOXA1 expression and survival outcomes in triple-negative breast cancer: A retrospective cohort study.PloS one
  • Beyond resveratrol: Vitis vinifera grape cane extracts selectively induce apoptosis in glioblastoma and triple-negative breast cancer cells via Bcl-2/Bax/Caspase-3 pathway.Fitoterapia
  • HOXC12 Expression in Triple-negative Breast Cancer: Clinicopathological Correlations and Potential as a Prognostic Biomarker.Current drug targets
  • ReviewThe HLA-E-NKG2A axis in breast cancer: an emerging NK-cell checkpoint and therapeutic target.Frontiers in immunology
  • Patient-reported outcomes from ASCENT-03: sacituzumab govitecan vs chemotherapy in advanced triple-negative breast cancer.The oncologist
  • Correction: Eustace et al. TP53 Mutation-Specific Dysregulation of Store-Operated Calcium Entry and Apoptotic Sensitivity in Triple-Negative Breast Cancer. Cancers 2025, 17, 1614.Cancers
  • Effectiveness and Toxicity Burden of Pembrolizumab in Combination With Neoadjuvant Chemotherapy for Stage II/III Triple Negative Breast Cancer: A Real-World Analysis From Alberta, Canada.American journal of clinical oncology
  • Real-world use of pembrolizumab in early-stage triple-negative breast cancer: Data from the French Early Access Program.Breast (Edinburgh, Scotland)
  • SIMMPYRA1 and SIMMPYRA2 suppress triple-negative breast cancer growth through selective STAT3 inhibition.Cell chemical biology
  • Relevance of toll-like receptor-4 in the pathogenesis of triple negative breast cancer.Molecular biology reports
  • CDK4/6-Mediated Growth Arrest Enhances Cell Stiffness and Contractility in RB-Proficient Triple-Negative Breast Cancer Cells in 3D Hydrogels.Tissue engineering. Part A
  • RBP1-driven retinol metabolism in tumor-associated lymphatic endothelial cells orchestrates triple-negative breast cancer progression and lymphatic metastasis.Experimental hematology & oncology
  • Treatment-associated remodeling of a mitochondrial translation-related gene set in paired pretreatment and residual triple-negative breast tumors.Neoplasia (New York, N.Y.)
  • Comprehensive characterization of the cellular and molecular consequences of LCN2 loss in MDA-MB-231 triple-negative breast cancer cells.Frontiers in cell and developmental biology
  • Claims-defined adrenal insufficiency, hypothyroidism, and type 1 diabetes after immune checkpoint inhibitor initiation in patients with triple-negative breast cancer in Japan.Breast cancer (Tokyo, Japan)
  • ReviewGlutamine as a context-dependent regulator controlling metabolism and immunity in triple-negative breast cancer.Cell communication and signaling : CCS
  • Meta-analysisReal-world effectiveness and safety of neoadjuvant pembrolizumab in early-stage triple-negative breast cancer: a systematic review and meta-analysis.BMC cancer
  • Analyzing per- and polyfluoroalkyl substances (PFAS) in triple-negative breast cancer (TNBC): an integrative transcriptomic and computational study.Cell biology and toxicology
  • Antibody-drug conjugates therapy for triple-negative breast cancer: a systematic review and meta-analysis.Frontiers in medicine